Format

Send to

Choose Destination
Mol Cell Endocrinol. 1995 Apr 28;110(1-2):213-23.

A quantitative assay for IGF-I and IGF binding protein mRNAs: expression in malignant melanoma cells.

Author information

1
Department of Pediatrics, Stanford University Medical Center, CA 94305, USA.

Abstract

The quantification of messenger RNA is central in studies of gene expression. We describe a quantitative assay for specific mRNAs (QASM) that measures mRNAs for insulin-like growth factor-I, IGF binding proteins (IGFBPs) -2, -3, -4, and -5, and beta-actin. The assay utilizes reverse transcription and polymerase chain reaction, followed by an ELISA based DNA assay technique. The use of internal (competitive) quantification standards gave poorly linear results, while external standards gave linear and reproducible results. QASM results correlated with IGFBP protein concentrations in conditioned medium and with mRNA levels determined by Northern blotting. QASM was used to study IGFBP expression in human malignant melanoma cells. Messenger RNA for IGFBP-2, -3, and -5 were present, while IGF-I and IGFBP-4 mRNAs were not detected. IGFBP-2 and -3 expression was increased in a dose dependent manner by treatment with IGF-I. Protein concentrations in conditioned media paralleled mRNA levels. QASM is a sensitive, specific, and reproducible approach to determining mRNA levels.

PMID:
7545621
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center